Neuren Pharmaceuticals
NEU.AX
#5122
Rank
HK$9.59 B
Marketcap
HK$73.75
Share price
4.80%
Change (1 day)
34.51%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2023: HK$1.08 B

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings (TTM) are HK$1.08 B. In 2023 the company made an earning of HK$1.08 B an increase over its 2022 earnings that were of HK$0.97 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2023

Annual earnings

Year Earnings Change
2023HK$1.08 B111519.63%
2022HK$0.97 M-102.21%
2021-HK$44.18 M-20%
2020-HK$55.22 M-6.83%
2019-HK$59.27 M-451.09%
2018HK$16.88 M-15.63%
2017HK$20 M-125.7%
2016-HK$77.87 M-3.06%
2015-HK$80.33 M51.1%
2014-HK$53.16 M-32.56%
2013-HK$78.82 M87.9%
2012-HK$41.95 M10.7%
2011-HK$37.9 M-3.79%
2010-HK$39.39 M21048.78%
2009-HK$0.19 M-99.77%
2008-HK$82.69 M-0.11%
2007-HK$82.78 M33.16%
2006-HK$62.17 M31.45%
2005-HK$47.29 M37.67%
2004-HK$34.35 M4.98%
2003-HK$32.72 M36.5%
2002-HK$23.98 M